Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...
NeoGenomics Announces Chief Executive Officer Succession
NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO ...